121 related articles for article (PubMed ID: 7484215)
1. Hydroxy- and non-hydroxy-galactolipids in developing rat CNS.
De Haas CG; Lopes-Cardozo M
Int J Dev Neurosci; 1995 Aug; 13(5):447-54. PubMed ID: 7484215
[TBL] [Abstract][Full Text] [Related]
2. Lead exposure affects levels of galactolipid metabolic enzymes in the developing rat brain.
Deng W; Poretz RD
Toxicol Appl Pharmacol; 2001 Apr; 172(2):98-107. PubMed ID: 11298496
[TBL] [Abstract][Full Text] [Related]
3. Progressive hypoxia inhibits the de novo synthesis of galactosylceramide in cultured oligodendrocytes.
Kendler A; Dawson G
J Biol Chem; 1990 Jul; 265(21):12259-66. PubMed ID: 2115515
[TBL] [Abstract][Full Text] [Related]
4. Effects of brefeldin A on galactosphingolipid synthesis in an immortalized Schwann cell line: evidence for different intracellular locations of galactosylceramide sulfotransferase and ceramide galactosyltransferase activities.
Farrer RG; Warden MP; Quarles RH
J Neurochem; 1995 Oct; 65(4):1865-73. PubMed ID: 7561886
[TBL] [Abstract][Full Text] [Related]
5. Changes in nervous system glycolipids during metamorphosis of Xenopus laevis.
Okamura N; Kishimoto Y
J Biol Chem; 1983 Oct; 258(20):12243-6. PubMed ID: 6630186
[TBL] [Abstract][Full Text] [Related]
6. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin.
Maldonado EN; Alderson NL; Monje PV; Wood PM; Hama H
J Lipid Res; 2008 Jan; 49(1):153-61. PubMed ID: 17901466
[TBL] [Abstract][Full Text] [Related]
7. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
8. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and transport of cerebrosides and sulfatides in rat brain during development.
Koul O; Singh I; Jungalwala FB
J Neurochem; 1988 Feb; 50(2):580-8. PubMed ID: 3121793
[TBL] [Abstract][Full Text] [Related]
10. Divalent cation-mediated interaction between cerebroside sulfate and cerebrosides: an investigation of the effect of structural variations of lipids by electrospray ionization mass spectrometry.
Koshy KM; Wang J; Boggs JM
Biophys J; 1999 Jul; 77(1):306-18. PubMed ID: 10388759
[TBL] [Abstract][Full Text] [Related]
11. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.
Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L
AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580
[TBL] [Abstract][Full Text] [Related]
12. Galactosylceramide sulfotransferase, arylsulfatase A and cerebroside sulfatase activity in different regions of developing rat brain.
van der Pal RH; Klein W; van Golde LM; Lopes-Cardozo M
Biochim Biophys Acta; 1990 Mar; 1043(1):91-6. PubMed ID: 1968763
[TBL] [Abstract][Full Text] [Related]
13. 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide.
Dasgupta S; Levery SB; Hogan EL
J Lipid Res; 2002 May; 43(5):751-61. PubMed ID: 11971946
[TBL] [Abstract][Full Text] [Related]
14. Sulfatide species with various fatty acid chains in oligodendrocytes at different developmental stages determined by imaging mass spectrometry.
Hirahara Y; Wakabayashi T; Mori T; Koike T; Yao I; Tsuda M; Honke K; Gotoh H; Ono K; Yamada H
J Neurochem; 2017 Feb; 140(3):435-450. PubMed ID: 27861899
[TBL] [Abstract][Full Text] [Related]
15. Effects of galactolipid elimination on oligodendrocyte development and myelination.
Marcus J; Dupree JL; Popko B
Glia; 2000 Jun; 30(4):319-28. PubMed ID: 10797612
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.
van der Bijl P; Strous GJ; Lopes-Cardozo M; Thomas-Oates J; van Meer G
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):589-97. PubMed ID: 8713090
[TBL] [Abstract][Full Text] [Related]
17. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic phases of galactocerebrosides: spectroscopic evidence of lamellar crystalline structures.
Bou Khalil M; Carrier D; Wong PT; Tanphaichitr N
Biochim Biophys Acta; 2001 Jun; 1512(2):158-70. PubMed ID: 11406093
[TBL] [Abstract][Full Text] [Related]
19. Myelin galactolipid synthesis in different strains of mice.
Sato C; Yu RK
J Neurochem; 1987 Oct; 49(4):1069-74. PubMed ID: 3625200
[TBL] [Abstract][Full Text] [Related]
20. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
Coetzee T; Dupree JL; Popko B
J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
